Purley, United Kingdom

Christopher John Marshall

This inventor holds 1 USPTO granted patent. Top assignee: Cancer Research Campaign Technology Limited. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christopher John Marshall. Retrieved from https://idiyas.com/inventor/christopher-john-marshall-j3snpy7q

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Christopher John Marshall

Introduction

Christopher John Marshall is a notable inventor based in Purley, GB. He has made significant contributions to the field of therapeutic research, particularly through his innovative methods for screening substances for therapeutic activity. His work is vital in advancing medical science and improving treatment options.

Latest Patents

Christopher holds 1 patent for his invention titled "Methods for screening of substances for therapeutic activity and yeast." This patent reflects his commitment to developing new methodologies that can enhance the effectiveness of therapeutic substances.

Career Highlights

Christopher is currently associated with Cancer Research Campaign Technology Limited, where he applies his expertise to further cancer research and treatment. His role in this organization underscores his dedication to improving health outcomes through scientific innovation.

Collaborations

Throughout his career, Christopher has collaborated with esteemed colleagues such as Alan Ashworth and David Anthony Hughes. These partnerships have allowed him to expand his research and contribute to significant advancements in the field.

Conclusion

Christopher John Marshall's work exemplifies the impact of innovation in therapeutic research. His contributions are paving the way for future advancements in cancer treatment and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…